Literature DB >> 17709882

The role of islet neogenesis-associated protein (INGAP) in islet neogenesis.

Mark Lipsett1, Stephen Hanley, Mauro Castellarin, Emily Austin, Wilma L Suarez-Pinzon, Alex Rabinovitch, Lawrence Rosenberg.   

Abstract

Islet Neogenesis-Associated Protein (INGAP) is a member of the Reg family of proteins implicated in various settings of endogenous pancreatic regeneration. The expression of INGAP and other RegIII proteins has also been linked temporally and spatially with the induction of islet neogenesis in animal models of disease and regeneration. Furthermore, administration of a peptide fragment of INGAP (INGAP peptide) has been demonstrated to reverse chemically induced diabetes as well as improve glycemic control and survival in an animal model of type 1 diabetes. Cultured human pancreatic tissue has also been shown to be responsive to INGAP peptide, producing islet-like structures with function, architecture and gene expression matching that of freshly isolated islets. Likewise, studies in normoglycemic animals show evidence of islet neogenesis. Finally, recent clinical studies suggest an effect of INGAP peptide to improve insulin production in type 1 diabetes and glycemic control in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709882     DOI: 10.1007/s12013-007-0028-3

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  11 in total

Review 1.  Reg3 Proteins as Gut Hormones?

Authors:  Jae Hoon Shin; Randy J Seeley
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

2.  Mechanisms of action of islet neogenesis-associated protein: comparison of the full-length recombinant protein and a bioactive peptide.

Authors:  Maria Petropavlovskaia; Jamal Daoud; Jonathan Zhu; Mandana Moosavi; Jieping Ding; Julia Makhlin; Beatrice Assouline-Thomas; Lawrence Rosenberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-31       Impact factor: 4.310

3.  Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline.

Authors:  Sarah A Tersey; Jeffery D Carter; Lawrence Rosenberg; David A Taylor-Fishwick; Raghavendra G Mirmira; Jerry L Nadler
Journal:  J Diabetes Mellitus       Date:  2012-05-01

4.  Nrf2/antioxidant pathway mediates β cell self-repair after damage by high-fat diet-induced oxidative stress.

Authors:  Tsehay Abebe; Jana Mahadevan; Lindsey Bogachus; Stephanie Hahn; Michele Black; Elizabeth Oseid; Fumihiko Urano; Vincenzo Cirulli; R Paul Robertson
Journal:  JCI Insight       Date:  2017-12-21

5.  Study on pancreatic islet adaptation and gene expression during pregnancy in rats.

Authors:  Ying Xue; Cuipin Liu; Yu Xu; Qinxin Yuan; Kuanfeng Xu; Xiaodong Mao; Guofang Chen; Xiaohong Wu; Mathias D Brendel; Chao Liu
Journal:  Endocrine       Date:  2009-11-08       Impact factor: 3.633

6.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

7.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03

8.  Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice.

Authors:  Klaus Pechhold; Kerstin Koczwara; Xiaolong Zhu; Victor S Harrison; Greg Walker; Janet Lee; David M Harlan
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

Review 9.  Pancreatic β Cell Mass Death.

Authors:  Husnia I Marrif; Salma I Al-Sunousi
Journal:  Front Pharmacol       Date:  2016-04-06       Impact factor: 5.810

Review 10.  Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development.

Authors:  Friedrich Mittermayer; Erica Caveney; Claudia De Oliveira; G Alexander Fleming; Loukas Gourgiotis; Mala Puri; Li-Jung Tai; J Rick Turner
Journal:  Curr Diabetes Rev       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.